Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Wouter Goutier"'
Autor:
Bart Stoops, Rob J. Vreeken, Chan Tang, Wim Bert Griet Schepens, Rameshwar U. Kadam, Jaap Goudsmit, Bart Rudolf Romanie Kesteleyn, Maria J. P. van Dongen, Wouter Goutier, Jan Vermond, Ronald Vogels, Boerries Brandenburg, Ian A. Wilson, Jarek Juraszek, Christophe Buyck, Robert H. E. Friesen
Publikováno v:
Science. 358:496-502
Broadly reactive drugs for flu Drugs for influenza are limited. For those available, viral resistance is rife. Part of the problem is that the virus is constantly mutating. Kadam et al. tested the cell entry stage of the virus life cycle as a drug ta
Autor:
Dirk Roymans, Wim Bert Griet Schepens, Danielle Peeters, Jaap Goudsmit, Maria J. P. van Dongen, Wenli Yu, Ronald Vogels, Bart Stoops, Boerries Brandenburg, J.M. Klap, Edward C. Lawson, Tim H. M. Jonckers, Mandy Jongeneelen, Harry A. van Diepen, Sven Blokland, Chan Tang, Wouter Goutier, Christophe Buyck, Ellen Lanckacker, Ian A. Wilson, Jan Vermond, P. Roevens, Wouter Koudstaal, Jin Wu, Frederike Schmitz, Rameshwar U. Kadam, Jarek Juraszek, Alida van Eijgen-Obregoso Real, Dashyant Dhanak, Pierre Jean-Marie Bernard Raboisson, Robert Heinz Edward Friesen, Divita Garg
Publikováno v:
Science. 363
A small molecule that targets influenza Many of us rely on seasonal vaccines for protection against influenza and are only too aware of their limited breadth. Broadly neutralizing antibodies (bnAbs) that target the conserved hemagglutinin (HA) stem o
Publikováno v:
Addiction Biology. 21:234-241
There are a number of approved therapeutics for the management of alcohol dependence, which might also convey the potential as smoking cessation aids. The present study investigated the effect of a few of these therapeutics and potential candidates (
Publikováno v:
Addiction Biology. 20:248-258
The present study focused on the evaluation of behavioral sensitization and cross-sensitization induced by nicotine and varenicline in rats. Furthermore, it examined the influence of varenicline, a partial alpha4beta2 nicotinic receptor agonist, on n
Publikováno v:
Addiction biology. 21(2)
There are a number of approved therapeutics for the management of alcohol dependence, which might also convey the potential as smoking cessation aids. The present study investigated the effect of a few of these therapeutics and potential candidates (
Publikováno v:
Addiction biology. 20(2)
The present study focused on the evaluation of behavioral sensitization and cross-sensitization induced by nicotine and varenicline in rats. Furthermore, it examined the influence of varenicline, a partial alpha4beta2 nicotinic receptor agonist, on n
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 25(6)
Behavioral sensitization is a phenomenon which can develop following repeated intermittent administration of a wide range of psychostimulants. The mechanism underlying this phenomenon is putatively involved in many neuropsychiatric disorders (incl. d
Autor:
Henri C. Wals, Vliet Bernard J Van, Josephus H. M. Lange, Alice J.M. Borst, Hicham Zilaout, Gijs D. Kuil, Martina A.W. van der Neut, Herman H. van Stuivenberg, Arnold P. den Hartog, Arie T. Mulder, Wouter Goutier
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(3)
The synthesis and structure–activity relationship studies of imidazoles are described. The target compounds 6 – 20 represent a novel chemotype of potent and CB 2 /CB 1 selective cannabinoid CB 2 receptor antagonists/inverse agonists with very hig
Autor:
Sharon Rosenzweig-Lipson, Deborah L. Smith, Feenstra Roelof W, Steven M. Grauer, Pierre Broqua, Rachel Navarra, David P. Rotella, Mark H. Pausch, Karen L. Marquis, Radka Graf, Albert J. Robichaud, Martina Van De Neut, Qian Lin, Claudine Pulicicchio, Farhana Pruthi, Wouter Goutier, Chad E. Beyer, Caitlin Wantuch, Julie A. Brennan, Zoë A. Hughes, Andrew C. McCreary, Margaret Lai, Chris G. Kruse
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 332(1)
The preclinical characterization of WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one] is described. In vitro binding and functional studies revealed highest affinity to the D(2) receptor (D(2L) K(i), 4.0 nM) and seroto